ReferenceID 3707

Antidepressant hyperforin up-regulates VEGF in CNS tumour cells

Pharmacol Res

Vascular endothelial growth factor (VEGF) is a key player in neo-angiogenesis; it sustains the progression of solid neoplasias, brain tumours included. It has recently been demonstrated that the use of antidepressants co

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final reference record.

Reference Id
3707
Evidence Id
20297
Core Evidence Id
20297
Source Reference Id
697
Herb2 Reference Id
HBREF001185
Subject Paper Key
HBIN029826_20883786
Pubmed Id
20883786
Doi
10.1016/j.phrs.2010.09.005
Paper Title
Antidepressant hyperforin up-regulates VEGF in CNS tumour cells
Paper Abstract
Vascular endothelial growth factor (VEGF) is a key player in neo-angiogenesis; it sustains the progression of solid neoplasias, brain tumours included. It has recently been demonstrated that the use of antidepressants correlates with increasing VEGF levels in the central nervous system (CNS). In order to elucidate whether the most used natural antidepressant [St. John's wort (SJW) extract] modulates VEGF expression, possible relationship between≤μM hyperforin (Hyp, the bioactive component in SJW) and VEGF in CNS tumours has been now examined in medulloblastoma and glioblastoma cells. Real-time PCR and ELISA revealed that under Hyp VEGF expression increased more than three fold in DAOY medulloblastoma cells; while, U87 glioblastoma cells - constitutively expressing high VEGF levels - showed no significant differences. Moreover, Hyp induced endothelial pro-angiogenic behaviour in a multi-parametric Matrigel colonisation assay, and down-modulation of pro-MMP-2 and pro-MMP-9 activities as measured by gelatin zymography. Should these results be confirmed in vivo for this and other types of CNS tumour, the antidepressant use of SJW extracts must be carefully re-considered, in particular for brain tumour patients.
Journal
Pharmacol Res
Publish Year
2011
Experiment Subject
medulloblastoma and glioblastoma cells
Experiment Type
Cell Experiment
Phenotype Related
Paper Title Cn
Paper Title En
Antidepressant hyperforin up-regulates VEGF in CNS tumour cells
Bilingual Status
semi_complete